A Randomized, Double-Blind, Placebo-Controlled Trial of Glycoprotein IIb/IIIa Inhibition With Abciximab in Patients with Diabetes Undergoing Percutaneous Coronary Intervention (ISAR-SWEET Trial)

  • Mehilli, Julinda
  • Kastrati, Adnan
  • Schömig, Albert MD

  • Deutsches Herzzentrum, Technische Universität, Munich, Germany

Circulation 111(13):p 1728, April 5, 2005.
Copyright © 2005 American Heart Association, Inc.